AusPAR: Leuprorelin

Australian Public Assessment Report

AusPAR

AusPAR: Leuprorelin [PDF, 586.23 KB]

AusPAR: Leuprorelin [Word, 1.33 MB]

Attachment: Product Information: Leuprorelin [PDF, 312.01 KB]

Attachment: Product Information: Leuprorelin [Word, 765.39 KB]

Attachment: Extract from Clinical Evaluation: Leuprorelin [PDF, 1.49 MB]

Attachment: Extract from Clinical Evaluation: Leuprorelin [Word, 6.35 MB]

Device/Product Name

Eligard

Active ingredients

Leuprorelin

AusPAR Date

5 September 2018

Published

24 October 2018

Submission Number

PM-2016-02330-1-4

Submission Type

Extension of indications

Decision

Approved